834 related articles for article (PubMed ID: 8809080)
1. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG
Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080
[TBL] [Abstract][Full Text] [Related]
2. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
Huang TF; Liu CZ; Ouyang CH; Teng CM
Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
[TBL] [Abstract][Full Text] [Related]
3. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
Rahman S; Lu X; Kakkar VV; Authi KS
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
Huang TF; Wang WJ; Teng CM; Ouyang C
Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
[TBL] [Abstract][Full Text] [Related]
5. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a role of glycoprotein IIb-IIIa, distinct from its ability to support aggregation, in platelet activation by ionophores in the presence of extracellular divalent cations.
Lages B; Weiss HJ
Blood; 1994 May; 83(9):2549-59. PubMed ID: 8167340
[TBL] [Abstract][Full Text] [Related]
7. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I
Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
[TBL] [Abstract][Full Text] [Related]
8. Role of platelet GpIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) release.
Mousa SA; Bozarth J; Forsythe M; Tsao P; Pease L; Reilly TM
Life Sci; 1994; 54(16):1155-62. PubMed ID: 8152339
[TBL] [Abstract][Full Text] [Related]
9. Platelet phospholipase D is activated by protein kinase C via an integrin alpha IIb beta 3-independent mechanism.
Martinson EA; Scheible S; Greinacher A; Presek P
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):623-8. PubMed ID: 7544577
[TBL] [Abstract][Full Text] [Related]
10. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
11. Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor.
Barre DE
Thromb Res; 2007; 119(5):601-7. PubMed ID: 16860375
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
[TBL] [Abstract][Full Text] [Related]
13. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
[TBL] [Abstract][Full Text] [Related]
14. Interspecies comparison of platelet aggregation, LIBS expression and clot retraction: observed differences in GPIIb-IIIa functional activity.
Jennings LK; White MM; Mandrell TD
Thromb Haemost; 1995 Dec; 74(6):1551-6. PubMed ID: 8772236
[TBL] [Abstract][Full Text] [Related]
15. Low structural specificity for nucleoside triphosphates as antagonists of ADP-induced platelet activation.
Greco NJ; Tandon NN; Jackson BW; Jamieson GA
J Biol Chem; 1992 Feb; 267(5):2966-70. PubMed ID: 1737752
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet mechanism of 2-chloro-3-(4-hexylphenyl)-amino-1,4-naphthoquinone (NQ304), an antithrombotic agent.
Zhang YH; Chung KH; Ryu CK; Lee YH; Kim TJ; Song YS; Hwang KA; Yun YP
Pharmacol Toxicol; 2001 Apr; 88(4):181-6. PubMed ID: 11322175
[TBL] [Abstract][Full Text] [Related]
18. Endogenous platelet fibrinogen surface expression on activated platelets.
Gralnick HR; Williams S; McKeown L; Connaghan G; Shafer B; Hansmann K; Vail M; Fenton J
J Lab Clin Med; 1991 Dec; 118(6):604-13. PubMed ID: 1744509
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect.
Gemmell CH; Sefton MV; Yeo EL
J Biol Chem; 1993 Jul; 268(20):14586-9. PubMed ID: 8325838
[TBL] [Abstract][Full Text] [Related]
20. Effects of ATP on ligand recognition of platelet fibrinogen receptor on GPIIb-IIIa.
Gawaz MP; Mayinger P; Neumann FJ
Am J Physiol; 1994 Sep; 267(3 Pt 2):H1098-106. PubMed ID: 8092274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]